The Future of U.S. Global Health Work in Asia – RAND

The United States is quietly recalibrating its global health strategy in one of the world’s most dynamic regions: Asia. As governments recover from the COVID-19 pandemic and brace for emerging threats-from new pathogens and antimicrobial resistance to climate-driven health crises-Washington’s long-standing health partnerships are under fresh scrutiny. A new analysis by the RAND Corporation examines how U.S. global health efforts in Asia are evolving, and what will be required to keep pace with shifting geopolitical realities, rising regional powers, and growing demands for resilient health systems. The findings arrive at a pivotal moment, as policymakers debate how best to align health investments with broader foreign policy goals while maintaining U.S. influence in a crowded and increasingly competitive landscape.

Reorienting U.S. Health Diplomacy in Asia Toward Pandemic Prevention and Regional Trust

As Asian governments recalibrate their post-COVID strategies, Washington faces pressure to shift from emergency aid and vaccine deliveries to a steadier focus on prevention, preparedness and trust-building. Analysts say this requires aligning U.S. health programs with regional priorities such as climate-sensitive disease surveillance, antimicrobial resistance and cross-border data sharing, rather than relying on one-off, high-visibility donations. Diplomats and health officials are increasingly urged to work through regional architectures-including ASEAN, APEC, and subregional public health networks-to create joint early-warning systems and interoperable reporting standards that outlast political cycles. The move also calls for rebalancing assistance away from a crisis-response mindset and toward local capacity, backing national laboratories, regulatory authorities and community health workers that can spot the next threat before it crosses borders.

Officials and experts note that credibility will hinge not only on how much the United States invests, but on how it listens. That means channeling support to locally led initiatives, ensuring transparent use of data, and separating health engagement from overt geostrategic messaging that can feed regional suspicions. In practice, this involves more joint research, staff exchanges and co-branded training centers with Asian partners, rather than purely U.S.-branded programs. It also means coordinating with other major donors to avoid duplication and visible rivalry. Below are emerging focus areas frequently cited by policymakers:

• Integrated surveillance that combines human, animal and environmental health signals.
• Shared standards for laboratory quality, clinical trials and regulatory review.
• Risk communication that counters misinformation without politicizing public health.
• Digital tools for secure, timely exchange of outbreak and genomic data.

This passage outlines how U.S. global health engagement in Asia is expected to evolve in the post-COVID period, and what regional partners are asking for.

Key points:

1. Strategic shift in focus
• Move away from one-off emergency aid and vaccine donations.
• Emphasize:

• Prevention and preparedness (early detection, long-term systems)
• Trust-building (listening, transparency, depoliticizing health)

2. Aligning with Asian regional priorities

U.S. programs should support:

• Climate-sensitive disease surveillance (e.g., monitoring vector-borne and climate-driven outbreaks)
• Antimicrobial resistance (AMR) control
• Cross-border and regional data sharing

3. Working through regional architectures
• Use ASEAN, APEC, and subregional public health networks as primary platforms.
• Build joint early-warning systems and interoperable reporting standards that continue across political cycles.

4. Building local capacity instead of crisis-only responses
• Strengthen national labs and regulators.
• Invest in community health workers and national public health institutions.
• Aim to help countries identify and manage threats before they become cross-border crises.

5. Credibility and trust
• Depends not just on U.S. funding levels, but on:

• Supporting locally led initiatives
• Transparent, responsible use of data
• Avoiding overt geopolitical signaling in health programs

• Emphasize joint research, staff exchanges, and co-branded training centers rather than purely U.S.-branded efforts.
• Coordinate with other donors to reduce duplication and visible great-power rivalry.

6. Emerging technical focus areas

Frequently cited priorities include:

• Integrated surveillance: combining human, animal, and environmental (One Health) data.
• Shared standards: lab quality, clinical trials, and regulatory review alignment.
• Risk communication: countering misinformation while keeping health messaging non-political.
• Digital tools: secure platforms for rapid sharing of outbreak and genomic data.

7. Illustrative roles and benefits (from the table)
• Pandemic surveillance

• U.S. role: fund networks, share analytics
• Regional benefit: faster detection of new threats

• Workforce training

• U.S. role: co-run field epidemiology training programs
• Regional benefit: stronger, more capable national response teams

• Vaccine R&D hubs

• U.S. role: support regional manufacturing and R&D capacity
• Regional benefit: quicker, more equitable access to vaccines in future crises

If you’d like, I can turn this into a policy brief, talking points, or a bullet summary tailored to a specific audience (e.g., U.S. officials, ASEAN counterparts, or an academic paper).

Harnessing Data Partnerships and Local Innovation to Strengthen Health Systems Across Asia

Across Asia, U.S. global health efforts are increasingly defined by how effectively they can connect fragmented data streams and emerging local technologies into a coherent decision-making ecosystem. Governments, universities, and start-ups are experimenting with shared data standards and secure, interoperable platforms that allow patient records, disease surveillance, and supply-chain information to move across borders and sectors. These collaborations are shifting from ad hoc information exchanges to formalized data partnerships governed by clear rules on privacy, ownership, and use. Within this evolving landscape, U.S.-backed initiatives are testing new models that leverage cloud-based analytics, rapid diagnostic tools, and community-generated data to detect outbreaks faster and allocate scarce resources more precisely.

At the same time, local innovators-from AI labs in Singapore to social enterprises in India and community health tech hubs in Vietnam-are designing tools that respond to the practical realities of overstretched clinics and rural health posts. U.S. engagement is moving toward co-development arrangements, in which regional partners drive product design while U.S. institutions provide technical support, funding, and pathways to scale. This approach emphasizes:

• Locally governed health data trusts to manage sensitive information.
• Digital tools in local languages optimized for low-bandwidth environments.
• Shared evaluation frameworks that compare what works across countries.
• Joint training programs that build regional data science and implementation capacity.

Final Thoughts

As Washington weighs its next moves, the RAND study underscores a pivotal choice: whether U.S. global health engagement in Asia will remain a patchwork of legacy programs and ad hoc crisis responses, or evolve into a more coherent, strategically aligned effort.

The findings suggest that decisions made in the coming years-on funding, partnerships, data sharing and health security priorities-will shape not only regional outcomes, but also U.S. influence in a part of the world central to future economic and geopolitical dynamics.

For now, the report stops short of predicting a single path forward. Instead, it points to a narrowing window in which the United States can recalibrate its role, strengthen trust with Asian partners and position health as a durable pillar of its broader engagement in the region.